 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0005337	nucleoside transmembrane transporter activity	1	9.481482e-4	1.000000e+0	1.000000e+0	1.054687e+3	9.481482e-4	1	9.481482e-4	1.000000e+0	1	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	SLC29A3
GO Molecular Function	GO:0015932	nucleobase-containing compound transmembrane transporter activity	2	1.878533e-3	1.000000e+0	1.000000e+0	5.323303e+2	1.878533e-3	1	1.878533e-3	1.000000e+0	3	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	SLC29A3
GO Molecular Function	GO:1901505	carbohydrate derivative transporter activity	3	1.904727e-3	1.000000e+0	1.000000e+0	5.250095e+2	1.904727e-3	1	1.904727e-3	1.000000e+0	2	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	SLC29A3
GO Molecular Function	GO:0022891	substrate-specific transmembrane transporter activity	4	8.482288e-2	1.000000e+0	1.000000e+0	1.178927e+1	8.482288e-2	1	8.482288e-2	1.000000e+0	4	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	SLC29A3
GO Molecular Function	GO:0022857	transmembrane transporter activity	5	9.170810e-2	1.000000e+0	1.000000e+0	1.090416e+1	9.170810e-2	1	9.170810e-2	1.000000e+0	5	9.802388e-2	1.000000e+0	1.000000e+0	9.945424e+0	1.005488e-1	1	907	5.000000e-1	1.102536e-3	unnamed	SLC29A3
GO Molecular Function	GO:0022892	substrate-specific transporter activity	6	9.245642e-2	1.000000e+0	1.000000e+0	1.081591e+1	9.245642e-2	1	9.245642e-2	1.000000e+0	6	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	SLC29A3
GO Molecular Function	GO:0005215	transporter activity	7	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	7	1.269529e-1	1.000000e+0	1.000000e+0	7.618666e+0	1.312566e-1	1	1184	5.000000e-1	8.445946e-4	unnamed	SLC29A3
GO Biological Process	GO:0015858	nucleoside transport	1	1.203402e-3	1.000000e+0	1.000000e+0	8.309778e+2	1.203402e-3	1	1.203402e-3	1.000000e+0	1	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	SLC29A3
GO Biological Process	GO:1901264	carbohydrate derivative transport	2	2.601076e-3	1.000000e+0	1.000000e+0	3.844563e+2	2.601076e-3	1	2.601076e-3	1.000000e+0	2	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	SLC29A3
GO Biological Process	GO:0015931	nucleobase-containing compound transport	3	1.181444e-2	1.000000e+0	1.000000e+0	8.464217e+1	1.181444e-2	1	1.181444e-2	1.000000e+0	3	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	SLC29A3
GO Biological Process	GO:0071705	nitrogen compound transport	4	3.671157e-2	1.000000e+0	1.000000e+0	2.723937e+1	3.671157e-2	1	3.671157e-2	1.000000e+0	4	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	SLC29A3
GO Biological Process	GO:0055085	transmembrane transport	5	8.563981e-2	1.000000e+0	1.000000e+0	1.167681e+1	8.563981e-2	1	8.563981e-2	1.000000e+0	5	9.602230e-2	1.000000e+0	1.000000e+0	1.015822e+1	9.844244e-2	1	888	5.000000e-1	1.126126e-3	unnamed	SLC29A3
GO Biological Process	GO:0071702	organic substance transport	6	1.396970e-1	1.000000e+0	1.000000e+0	7.158351e+0	1.396970e-1	1	1.396970e-1	1.000000e+0	6	1.786811e-1	1.000000e+0	1.000000e+0	5.334418e+0	1.874619e-1	1	1691	5.000000e-1	5.913661e-4	unnamed	SLC29A3
GO Biological Process	GO:0044765	single-organism transport	7	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	7	2.680389e-1	1.000000e+0	1.000000e+0	3.461435e+0	2.888975e-1	1	2606	5.000000e-1	3.837299e-4	unnamed	SLC29A3
GO Biological Process	GO:0006810	transport	8	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	8	3.291182e-1	1.000000e+0	1.000000e+0	2.763634e+0	3.618425e-1	1	3264	5.000000e-1	3.063725e-4	unnamed	SLC29A3
GO Biological Process	GO:0051234	establishment of localization	9	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	9	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	SLC29A3
GO Biological Process	GO:0051179	localization	10	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	10	3.970433e-1	1.000000e+0	1.000000e+0	2.237227e+0	4.469819e-1	1	4032	5.000000e-1	2.480159e-4	unnamed	SLC29A3
GO Biological Process	GO:0044763	single-organism cellular process	11	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	11	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	SLC29A3
GO Biological Process	GO:0044699	single-organism process	12	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	12	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	SLC29A3
GO Biological Process	GO:0009987	cellular process	13	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	13	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	SLC29A3
GO Cellular Component	GO:0031902	late endosome membrane	1	6.965144e-3	1.000000e+0	1.000000e+0	1.435720e+2	6.965144e-3	1	6.965144e-3	1.000000e+0	1	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	SLC29A3
GO Cellular Component	GO:0005770	late endosome	2	1.416408e-2	1.000000e+0	1.000000e+0	7.060114e+1	1.416408e-2	1	1.416408e-2	1.000000e+0	2	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	SLC29A3
GO Cellular Component	GO:0005765	lysosomal membrane	3	1.703566e-2	1.000000e+0	1.000000e+0	5.870040e+1	1.703566e-2	1	1.703566e-2	1.000000e+0	3	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	SLC29A3
GO Cellular Component	GO:0005774	vacuolar membrane	4	1.938484e-2	1.000000e+0	1.000000e+0	5.158669e+1	1.938484e-2	1	1.938484e-2	1.000000e+0	4	3.025460e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	275	5.000000e-1	3.636364e-3	unnamed	SLC29A3
GO Cellular Component	GO:0044437	vacuolar part	5	2.563587e-2	1.000000e+0	1.000000e+0	3.900784e+1	2.563587e-2	1	2.563587e-2	1.000000e+0	7	3.809903e-2	1.000000e+0	1.000000e+0	2.599568e+1	3.846793e-2	1	347	5.000000e-1	2.881844e-3	unnamed	SLC29A3
GO Cellular Component	GO:0010008	endosome membrane	6	3.045322e-2	1.000000e+0	1.000000e+0	3.283725e+1	3.045322e-2	1	3.045322e-2	1.000000e+0	5	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	SLC29A3
GO Cellular Component	GO:0044440	endosomal part	7	3.120904e-2	1.000000e+0	1.000000e+0	3.204200e+1	3.120904e-2	1	3.120904e-2	1.000000e+0	6	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	SLC29A3
GO Cellular Component	GO:0005764	lysosome	8	3.379592e-2	1.000000e+0	1.000000e+0	2.958937e+1	3.379592e-2	1	3.379592e-2	1.000000e+0	8	4.731883e-2	1.000000e+0	1.000000e+0	2.088079e+1	4.789092e-2	1	432	5.000000e-1	2.314815e-3	unnamed	SLC29A3
GO Cellular Component	GO:0005773	vacuole	9	3.796075e-2	1.000000e+0	1.000000e+0	2.634300e+1	3.796075e-2	1	3.796075e-2	1.000000e+0	9	5.358449e-2	1.000000e+0	1.000000e+0	1.840918e+1	5.432071e-2	1	490	5.000000e-1	2.040816e-3	unnamed	SLC29A3
GO Cellular Component	GO:0005768	endosome	10	5.727050e-2	1.000000e+0	1.000000e+0	1.746100e+1	5.727050e-2	1	5.727050e-2	1.000000e+0	10	6.562521e-2	1.000000e+0	1.000000e+0	1.498422e+1	6.673688e-2	1	602	5.000000e-1	1.661130e-3	unnamed	SLC29A3
GO Cellular Component	GO:0031090	organelle membrane	11	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	15	2.650007e-1	1.000000e+0	1.000000e+0	3.504468e+0	2.853500e-1	1	2574	5.000000e-1	3.885004e-4	unnamed	SLC29A3
GO Cellular Component	GO:0016021	integral to membrane	12	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	11	8.502701e-2	1.000000e+0	1.000000e+0	3.429196e+0	5.832271e-1	2	5261	1.000000e+0	3.801559e-4	unnamed	C10orf105,SLC29A3
GO Cellular Component	GO:0031224	intrinsic to membrane	13	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	12	8.871915e-2	1.000000e+0	1.000000e+0	3.357090e+0	5.957541e-1	2	5374	1.000000e+0	3.721623e-4	unnamed	C10orf105,SLC29A3
GO Cellular Component	GO:0044446	intracellular organelle part	14	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	16	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	SLC29A3
GO Cellular Component	GO:0044422	organelle part	15	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	17	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	SLC29A3
GO Cellular Component	GO:0044444	cytoplasmic part	16	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	18	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	SLC29A3
GO Cellular Component	GO:0044425	membrane part	17	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	13	1.178243e-1	1.000000e+0	1.000000e+0	2.913128e+0	6.865473e-1	2	6193	1.000000e+0	3.229453e-4	unnamed	C10orf105,SLC29A3
GO Cellular Component	GO:0016020	membrane	18	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	14	1.895088e-1	1.000000e+0	1.000000e+0	2.297046e+0	8.706834e-1	2	7854	1.000000e+0	2.546473e-4	unnamed	C10orf105,SLC29A3
GO Cellular Component	GO:0005737	cytoplasm	19	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	19	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	SLC29A3
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	20	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	20	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	SLC29A3
GO Cellular Component	GO:0043227	membrane-bounded organelle	21	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	21	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	SLC29A3
GO Cellular Component	GO:0043229	intracellular organelle	22	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	22	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	SLC29A3
GO Cellular Component	GO:0043226	organelle	23	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	23	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	SLC29A3
GO Cellular Component	GO:0044424	intracellular part	24	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	24	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	SLC29A3
GO Cellular Component	GO:0005622	intracellular	25	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	25	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	SLC29A3
GO Cellular Component	GO:0044464	cell part	26	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	26	9.677154e-1	1.000000e+0	1.000000e+0	6.095344e-1	1.640596e+0	1	14799	5.000000e-1	6.757213e-5	unnamed	SLC29A3
GO Cellular Component	GO:0005623	cell	27	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	27	9.677354e-1	1.000000e+0	1.000000e+0	6.094932e-1	1.640707e+0	1	14800	5.000000e-1	6.756757e-5	unnamed	SLC29A3
Mouse Phenotype	MP:0011080	increased macrophage apoptosis	1	9.306449e-4	1.000000e+0	1.000000e+0	1.074524e+3	9.306449e-4	1	9.306449e-4	1.000000e+0	1	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	SLC29A3
Mouse Phenotype	MP:0011073	abnormal macrophage apoptosis	2	1.467544e-3	1.000000e+0	1.000000e+0	6.814104e+2	1.467544e-3	1	1.467544e-3	1.000000e+0	2	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC29A3
Mouse Phenotype	MP:0003172	abnormal lysosome physiology	3	2.635841e-3	1.000000e+0	1.000000e+0	3.793856e+2	2.635841e-3	1	2.635841e-3	1.000000e+0	4	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	SLC29A3
Mouse Phenotype	MP:0009321	increased histiocytic sarcoma incidence	4	2.651022e-3	1.000000e+0	1.000000e+0	3.772129e+2	2.651022e-3	1	2.651022e-3	1.000000e+0	3	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	SLC29A3
Mouse Phenotype	MP:0010373	myeloid hyperplasia	5	4.032918e-3	1.000000e+0	1.000000e+0	2.479594e+2	4.032918e-3	1	4.032918e-3	1.000000e+0	5	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	SLC29A3
Mouse Phenotype	MP:0009788	increased susceptibility to bacterial infection induced morbidity/mortality	6	5.573754e-3	1.000000e+0	1.000000e+0	1.794123e+2	5.573754e-3	1	5.573754e-3	1.000000e+0	6	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	SLC29A3
Mouse Phenotype	MP:0009787	increased susceptibility to infection induced morbidity/mortality	7	8.656384e-3	1.000000e+0	1.000000e+0	1.155217e+2	8.656384e-3	1	8.656384e-3	1.000000e+0	7	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0009785	altered susceptibility to infection induced morbidity/mortality	8	1.139315e-2	1.000000e+0	1.000000e+0	8.777207e+1	1.139315e-2	1	1.139315e-2	1.000000e+0	11	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002032	sarcoma	9	1.184575e-2	1.000000e+0	1.000000e+0	8.441844e+1	1.184575e-2	1	1.184575e-2	1.000000e+0	8	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0001601	abnormal myelopoiesis	10	1.302171e-2	1.000000e+0	1.000000e+0	7.679483e+1	1.302171e-2	1	1.302171e-2	1.000000e+0	9	1.347939e-2	1.000000e+0	1.000000e+0	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0000240	extramedullary hematopoiesis	11	1.501925e-2	1.000000e+0	1.000000e+0	6.658121e+1	1.501925e-2	1	1.501925e-2	1.000000e+0	12	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0005425	increased macrophage cell number	12	1.735368e-2	1.000000e+0	1.000000e+0	5.762467e+1	1.735368e-2	1	1.735368e-2	1.000000e+0	10	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0000702	enlarged lymph nodes	13	1.807915e-2	1.000000e+0	1.000000e+0	5.531233e+1	1.807915e-2	1	1.807915e-2	1.000000e+0	13	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002412	increased susceptibility to bacterial infection	14	2.165110e-2	1.000000e+0	1.000000e+0	4.618702e+1	2.165110e-2	1	2.165110e-2	1.000000e+0	17	3.189148e-2	1.000000e+0	1.000000e+0	3.110517e+1	3.214899e-2	1	290	5.000000e-1	3.448276e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002022	increased lymphoma incidence	15	2.227473e-2	1.000000e+0	1.000000e+0	4.489392e+1	2.227473e-2	1	2.227473e-2	1.000000e+0	14	2.413134e-2	1.000000e+0	1.000000e+0	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0000701	abnormal lymph node size	16	2.438817e-2	1.000000e+0	1.000000e+0	4.100349e+1	2.438817e-2	1	2.438817e-2	1.000000e+0	15	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0010296	increased hemolymphoid system tumor incidence	17	2.613114e-2	1.000000e+0	1.000000e+0	3.826852e+1	2.613114e-2	1	2.613114e-2	1.000000e+0	16	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002339	abnormal lymph node morphology	18	3.392160e-2	1.000000e+0	1.000000e+0	2.947974e+1	3.392160e-2	1	3.392160e-2	1.000000e+0	19	3.701143e-2	1.000000e+0	1.000000e+0	2.676706e+1	3.735935e-2	1	337	5.000000e-1	2.967359e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002018	malignant tumors	19	3.474739e-2	1.000000e+0	1.000000e+0	2.877914e+1	3.474739e-2	1	3.474739e-2	1.000000e+0	18	3.646740e-2	1.000000e+0	1.000000e+0	2.717018e+1	3.680506e-2	1	332	5.000000e-1	3.012048e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002451	abnormal macrophage physiology	20	3.533810e-2	1.000000e+0	1.000000e+0	2.829807e+1	3.533810e-2	1	3.533810e-2	1.000000e+0	20	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002406	increased susceptibility to infection	21	3.565592e-2	1.000000e+0	1.000000e+0	2.804583e+1	3.565592e-2	1	3.565592e-2	1.000000e+0	23	4.861687e-2	1.000000e+0	1.000000e+0	2.031644e+1	4.922122e-2	1	444	5.000000e-1	2.252252e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002446	abnormal macrophage morphology	22	4.095716e-2	1.000000e+0	1.000000e+0	2.441576e+1	4.095716e-2	1	4.095716e-2	1.000000e+0	21	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0001793	altered susceptibility to infection	23	4.268939e-2	1.000000e+0	1.000000e+0	2.342503e+1	4.268939e-2	1	4.268939e-2	1.000000e+0	27	5.918441e-2	1.000000e+0	1.000000e+0	1.664299e+1	6.008536e-2	1	542	5.000000e-1	1.845018e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0000691	enlarged spleen	24	4.312302e-2	1.000000e+0	1.000000e+0	2.318947e+1	4.312302e-2	1	4.312302e-2	1.000000e+0	22	4.840059e-2	1.000000e+0	1.000000e+0	2.040837e+1	4.899950e-2	1	442	5.000000e-1	2.262443e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0005025	abnormal response to infection	25	4.712582e-2	1.000000e+0	1.000000e+0	2.121979e+1	4.712582e-2	1	4.712582e-2	1.000000e+0	29	6.315885e-2	1.000000e+0	1.000000e+0	1.557945e+1	6.418713e-2	1	579	5.000000e-1	1.727116e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0008248	abnormal mononuclear phagocyte morphology	26	4.981952e-2	1.000000e+0	1.000000e+0	2.007245e+1	4.981952e-2	1	4.981952e-2	1.000000e+0	24	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0001657	abnormal induced morbidity/mortality	27	5.088453e-2	1.000000e+0	1.000000e+0	1.965234e+1	5.088453e-2	1	5.088453e-2	1.000000e+0	28	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002419	abnormal innate immunity	28	5.385019e-2	1.000000e+0	1.000000e+0	1.857003e+1	5.385019e-2	1	5.385019e-2	1.000000e+0	29	6.315885e-2	1.000000e+0	1.000000e+0	1.557945e+1	6.418713e-2	1	579	5.000000e-1	1.727116e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0010273	increased classified tumor incidence	29	5.452900e-2	1.000000e+0	1.000000e+0	1.833887e+1	5.452900e-2	1	5.452900e-2	1.000000e+0	25	5.563254e-2	1.000000e+0	1.000000e+0	1.772200e+1	5.642703e-2	1	509	5.000000e-1	1.964637e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0010274	increased organ/body region tumor incidence	30	5.980108e-2	1.000000e+0	1.000000e+0	1.672211e+1	5.980108e-2	1	5.980108e-2	1.000000e+0	26	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0008251	abnormal phagocyte morphology	31	6.342112e-2	1.000000e+0	1.000000e+0	1.576762e+1	6.342112e-2	1	6.342112e-2	1.000000e+0	32	6.905126e-2	1.000000e+0	1.000000e+0	1.422792e+1	7.028435e-2	1	634	5.000000e-1	1.577287e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002224	abnormal spleen size	32	6.692526e-2	1.000000e+0	1.000000e+0	1.494204e+1	6.692526e-2	1	6.692526e-2	1.000000e+0	33	6.947907e-2	1.000000e+0	1.000000e+0	1.413871e+1	7.072779e-2	1	638	5.000000e-1	1.567398e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0008195	abnormal professional antigen presenting cell morphology	33	6.835128e-2	1.000000e+0	1.000000e+0	1.463030e+1	6.835128e-2	1	6.835128e-2	1.000000e+0	34	7.332497e-2	1.000000e+0	1.000000e+0	1.338353e+1	7.471870e-2	1	674	5.000000e-1	1.483680e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002020	increased tumor incidence	34	7.037685e-2	1.000000e+0	1.000000e+0	1.420922e+1	7.037685e-2	1	7.037685e-2	1.000000e+0	31	6.873033e-2	1.000000e+0	1.000000e+0	1.429556e+1	6.995178e-2	1	631	5.000000e-1	1.584786e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0008250	abnormal myeloid leukocyte morphology	35	7.384491e-2	1.000000e+0	1.000000e+0	1.354189e+1	7.384491e-2	1	7.384491e-2	1.000000e+0	38	8.120541e-2	1.000000e+0	1.000000e+0	1.205949e+1	8.292223e-2	1	748	5.000000e-1	1.336898e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002019	abnormal tumor incidence	36	7.769090e-2	1.000000e+0	1.000000e+0	1.287152e+1	7.769090e-2	1	7.769090e-2	1.000000e+0	35	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002166	altered tumor susceptibility	37	7.903444e-2	1.000000e+0	1.000000e+0	1.265271e+1	7.903444e-2	1	7.903444e-2	1.000000e+0	36	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002452	abnormal professional antigen presenting cell physiology	38	8.156256e-2	1.000000e+0	1.000000e+0	1.226053e+1	8.156256e-2	1	8.156256e-2	1.000000e+0	44	9.433504e-2	1.000000e+0	1.000000e+0	1.034461e+1	9.666870e-2	1	872	5.000000e-1	1.146789e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0000689	abnormal spleen morphology	39	8.333506e-2	1.000000e+0	1.000000e+0	1.199975e+1	8.333506e-2	1	8.333506e-2	1.000000e+0	40	8.979273e-2	1.000000e+0	1.000000e+0	1.088118e+1	9.190178e-2	1	829	5.000000e-1	1.206273e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0006042	increased apoptosis	40	8.429662e-2	1.000000e+0	1.000000e+0	1.186287e+1	8.429662e-2	1	8.429662e-2	1.000000e+0	37	7.939802e-2	1.000000e+0	1.000000e+0	1.233995e+1	8.103764e-2	1	731	5.000000e-1	1.367989e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0000218	increased leukocyte cell number	41	8.449829e-2	1.000000e+0	1.000000e+0	1.183456e+1	8.449829e-2	1	8.449829e-2	1.000000e+0	42	9.296298e-2	1.000000e+0	1.000000e+0	1.050116e+1	9.522754e-2	1	859	5.000000e-1	1.164144e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002006	tumorigenesis	42	8.579997e-2	1.000000e+0	1.000000e+0	1.165502e+1	8.579997e-2	1	8.579997e-2	1.000000e+0	39	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002221	abnormal lymph organ size	43	8.616517e-2	1.000000e+0	1.000000e+0	1.160562e+1	8.616517e-2	1	8.616517e-2	1.000000e+0	41	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0005460	abnormal leukopoiesis	44	8.694600e-2	1.000000e+0	1.000000e+0	1.150139e+1	8.694600e-2	1	8.694600e-2	1.000000e+0	43	9.306856e-2	1.000000e+0	1.000000e+0	1.048895e+1	9.533840e-2	1	860	5.000000e-1	1.162791e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0011181	increased hematopoietic cell number	45	9.359664e-2	1.000000e+0	1.000000e+0	1.068414e+1	9.359664e-2	1	9.359664e-2	1.000000e+0	45	1.045399e-1	1.000000e+0	1.000000e+0	9.309082e+0	1.074220e-1	1	969	5.000000e-1	1.031992e-3	unnamed	SLC29A3
Mouse Phenotype	MP:0002722	abnormal immune system organ morphology	46	1.102968e-1	1.000000e+0	1.000000e+0	9.066446e+0	1.102968e-1	1	1.102968e-1	1.000000e+0	46	1.202068e-1	1.000000e+0	1.000000e+0	8.061215e+0	1.240508e-1	1	1119	5.000000e-1	8.936550e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0002442	abnormal leukocyte physiology	47	1.192967e-1	1.000000e+0	1.000000e+0	8.382459e+0	1.192967e-1	1	1.192967e-1	1.000000e+0	48	1.356324e-1	1.000000e+0	1.000000e+0	7.113959e+0	1.405687e-1	1	1268	5.000000e-1	7.886435e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0001819	abnormal immune cell physiology	48	1.203217e-1	1.000000e+0	1.000000e+0	8.311053e+0	1.203217e-1	1	1.203217e-1	1.000000e+0	51	1.380014e-1	1.000000e+0	1.000000e+0	6.987219e+0	1.431185e-1	1	1291	5.000000e-1	7.745933e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0002421	abnormal cell-mediated immunity	49	1.209554e-1	1.000000e+0	1.000000e+0	8.267508e+0	1.209554e-1	1	1.209554e-1	1.000000e+0	52	1.391333e-1	1.000000e+0	1.000000e+0	6.928187e+0	1.443379e-1	1	1302	5.000000e-1	7.680492e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0001648	abnormal apoptosis	50	1.225891e-1	1.000000e+0	1.000000e+0	8.157331e+0	1.225891e-1	1	1.225891e-1	1.000000e+0	47	1.205188e-1	1.000000e+0	1.000000e+0	8.039661e+0	1.243833e-1	1	1122	5.000000e-1	8.912656e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0002420	abnormal adaptive immunity	51	1.226687e-1	1.000000e+0	1.000000e+0	8.152037e+0	1.226687e-1	1	1.226687e-1	1.000000e+0	54	1.408810e-1	1.000000e+0	1.000000e+0	6.838893e+0	1.462225e-1	1	1319	5.000000e-1	7.581501e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0000217	abnormal leukocyte cell number	52	1.272684e-1	1.000000e+0	1.000000e+0	7.857411e+0	1.272684e-1	1	1.272684e-1	1.000000e+0	53	1.403671e-1	1.000000e+0	1.000000e+0	6.864916e+0	1.456682e-1	1	1314	5.000000e-1	7.610350e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0008247	abnormal mononuclear cell morphology	53	1.350005e-1	1.000000e+0	1.000000e+0	7.407378e+0	1.350005e-1	1	1.350005e-1	1.000000e+0	55	1.540854e-1	1.000000e+0	1.000000e+0	6.229627e+0	1.605233e-1	1	1448	5.000000e-1	6.906077e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0000313	abnormal cell death	54	1.373532e-1	1.000000e+0	1.000000e+0	7.280503e+0	1.373532e-1	1	1.373532e-1	1.000000e+0	50	1.377955e-1	1.000000e+0	1.000000e+0	6.998061e+0	1.428967e-1	1	1289	5.000000e-1	7.757952e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0011180	abnormal hematopoietic cell number	55	1.429801e-1	1.000000e+0	1.000000e+0	6.993980e+0	1.429801e-1	1	1.429801e-1	1.000000e+0	56	1.595825e-1	1.000000e+0	1.000000e+0	6.005659e+0	1.665096e-1	1	1502	5.000000e-1	6.657790e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0002083	premature death	56	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	49	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0008246	abnormal leukocyte morphology	57	1.497188e-1	1.000000e+0	1.000000e+0	6.679189e+0	1.497188e-1	1	1.497188e-1	1.000000e+0	57	1.698159e-1	1.000000e+0	1.000000e+0	5.627261e+0	1.777063e-1	1	1603	5.000000e-1	6.238303e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0000716	abnormal immune system cell morphology	58	1.505458e-1	1.000000e+0	1.000000e+0	6.642496e+0	1.505458e-1	1	1.505458e-1	1.000000e+0	58	1.710276e-1	1.000000e+0	1.000000e+0	5.585449e+0	1.790366e-1	1	1615	5.000000e-1	6.191950e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0002123	abnormal hematopoiesis	59	1.777183e-1	1.000000e+0	1.000000e+0	5.626882e+0	1.777183e-1	1	1.777183e-1	1.000000e+0	60	2.055841e-1	1.000000e+0	1.000000e+0	4.599949e+0	2.173937e-1	1	1961	5.000000e-1	5.099439e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0002429	abnormal blood cell morphology/development	60	1.793335e-1	1.000000e+0	1.000000e+0	5.576203e+0	1.793335e-1	1	1.793335e-1	1.000000e+0	61	2.074604e-1	1.000000e+0	1.000000e+0	4.555808e+0	2.195000e-1	1	1980	5.000000e-1	5.050505e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0000685	abnormal immune system morphology	61	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	59	2.020229e-1	1.000000e+0	1.000000e+0	4.685974e+0	2.134028e-1	1	1925	5.000000e-1	5.194805e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0001790	abnormal immune system physiology	62	1.911135e-1	1.000000e+0	1.000000e+0	5.232494e+0	1.911135e-1	1	1.911135e-1	1.000000e+0	62	2.153363e-1	1.000000e+0	1.000000e+0	4.378883e+0	2.283687e-1	1	2060	5.000000e-1	4.854369e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	63	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	63	2.274661e-1	1.000000e+0	1.000000e+0	4.130266e+0	2.421152e-1	1	2184	5.000000e-1	4.578755e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	64	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	64	2.333986e-1	1.000000e+0	1.000000e+0	4.018040e+0	2.488776e-1	1	2245	5.000000e-1	4.454343e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0005387	immune system phenotype	65	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	65	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0005621	abnormal cell physiology	66	3.078333e-1	1.000000e+0	1.000000e+0	3.248512e+0	3.078333e-1	1	3.078333e-1	1.000000e+0	66	3.046545e-1	1.000000e+0	1.000000e+0	3.009843e+0	3.322432e-1	1	2997	5.000000e-1	3.336670e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0005384	cellular phenotype	67	3.121556e-1	1.000000e+0	1.000000e+0	3.203530e+0	3.121556e-1	1	3.121556e-1	1.000000e+0	67	3.123982e-1	1.000000e+0	1.000000e+0	2.927783e+0	3.415553e-1	1	3081	5.000000e-1	3.245699e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0010769	abnormal survival	68	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	68	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0010768	mortality/aging	69	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	69	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	SLC29A3
Mouse Phenotype	MP:0000001	mammalian phenotype	70	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	70	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	SLC29A3
Human Phenotype	HP:0005200	Retroperitoneal fibrosis	1	1.765782e-4	1.000000e+0	1.000000e+0	5.663212e+3	1.765782e-4	1	1.765782e-4	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC29A3
Human Phenotype	HP:0100534	Episcleritis	2	1.787146e-4	1.000000e+0	5.491900e-1	5.595512e+3	1.787146e-4	1	1.787146e-4	1.000000e+0	2	2.217111e-4	1.000000e+0	6.813182e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	SLC29A3
Human Phenotype	HP:0002585	Abnormality of the peritoneum	3	9.832578e-4	1.000000e+0	1.000000e+0	1.017027e+3	9.832578e-4	1	9.832578e-4	1.000000e+0	3	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	SLC29A3
Human Phenotype	HP:0001640	Cardiomegaly	4	1.646993e-3	1.000000e+0	1.000000e+0	6.071671e+2	1.646993e-3	1	1.646993e-3	1.000000e+0	8	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	SLC29A3
Human Phenotype	HP:0000815	Hypergonadotropic hypogonadism	5	2.309165e-3	1.000000e+0	1.000000e+0	4.330569e+2	2.309165e-3	1	2.309165e-3	1.000000e+0	4	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	SLC29A3
Human Phenotype	HP:0002987	Elbow flexion contracture	6	3.435237e-3	1.000000e+0	1.000000e+0	2.911007e+2	3.435237e-3	1	3.435237e-3	1.000000e+0	11	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	SLC29A3
Human Phenotype	HP:0001945	Fever	7	3.941407e-3	1.000000e+0	1.000000e+0	2.537165e+2	3.941407e-3	1	3.941407e-3	1.000000e+0	12	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	SLC29A3
Human Phenotype	HP:0001822	Hallux valgus	8	4.298664e-3	1.000000e+0	1.000000e+0	2.326304e+2	4.298664e-3	1	4.298664e-3	1.000000e+0	5	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	SLC29A3
Human Phenotype	HP:0010051	Deviation/Displacement of the hallux	9	4.453148e-3	1.000000e+0	1.000000e+0	2.245603e+2	4.453148e-3	1	4.453148e-3	1.000000e+0	6	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	SLC29A3
Human Phenotype	HP:0001634	Mitral valve prolapse	10	4.467072e-3	1.000000e+0	1.000000e+0	2.238603e+2	4.467072e-3	1	4.467072e-3	1.000000e+0	8	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	SLC29A3
Human Phenotype	HP:0000591	Abnormality of the sclera	11	4.512551e-3	1.000000e+0	1.000000e+0	2.216041e+2	4.512551e-3	1	4.512551e-3	1.000000e+0	12	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	SLC29A3
Human Phenotype	HP:0000824	Growth hormone deficiency	12	4.836362e-3	1.000000e+0	1.000000e+0	2.067670e+2	4.836362e-3	1	4.836362e-3	1.000000e+0	7	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	SLC29A3
Human Phenotype	HP:0100498	Deviation of toes	13	4.917655e-3	1.000000e+0	1.000000e+0	2.033489e+2	4.917655e-3	1	4.917655e-3	1.000000e+0	8	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	SLC29A3
Human Phenotype	HP:0002996	Limited elbow movement	14	6.470096e-3	1.000000e+0	1.000000e+0	1.545572e+2	6.470096e-3	1	6.470096e-3	1.000000e+0	15	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	SLC29A3
Human Phenotype	HP:0010701	Abnormal immunoglobulin level	15	7.055509e-3	1.000000e+0	1.000000e+0	1.417332e+2	7.055509e-3	1	7.055509e-3	1.000000e+0	24	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	SLC29A3
Human Phenotype	HP:0005372	Abnormality of B cell physiology	16	7.105981e-3	1.000000e+0	1.000000e+0	1.407265e+2	7.105981e-3	1	7.105981e-3	1.000000e+0	26	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	SLC29A3
Human Phenotype	HP:0100533	Inflammatory abnormality of the eye	17	7.180633e-3	1.000000e+0	1.000000e+0	1.392635e+2	7.180633e-3	1	7.180633e-3	1.000000e+0	21	1.017327e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	SLC29A3
Human Phenotype	HP:0002846	Abnormality of B cells	18	7.276330e-3	1.000000e+0	1.000000e+0	1.374319e+2	7.276330e-3	1	7.276330e-3	1.000000e+0	27	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	SLC29A3
Human Phenotype	HP:0005368	Abnormality of humoral immunity	19	7.880175e-3	1.000000e+0	1.000000e+0	1.269007e+2	7.880175e-3	1	7.880175e-3	1.000000e+0	28	1.215761e-2	1.000000e+0	1.000000e+0	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	SLC29A3
Human Phenotype	HP:0001844	Abnormality of the hallux	20	8.297908e-3	1.000000e+0	1.000000e+0	1.205123e+2	8.297908e-3	1	8.297908e-3	1.000000e+0	14	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	SLC29A3
Human Phenotype	HP:0001633	Abnormality of the mitral valve	21	9.002976e-3	1.000000e+0	1.000000e+0	1.110744e+2	9.002976e-3	1	9.002976e-3	1.000000e+0	17	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	SLC29A3
Human Phenotype	HP:0006705	Abnormality of the atrioventricular valves	22	9.578845e-3	1.000000e+0	1.000000e+0	1.043967e+2	9.578845e-3	1	9.578845e-3	1.000000e+0	18	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	SLC29A3
Human Phenotype	HP:0002716	Lymphadenopathy	23	9.751195e-3	1.000000e+0	1.000000e+0	1.025515e+2	9.751195e-3	1	9.751195e-3	1.000000e+0	20	1.006297e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	SLC29A3
Human Phenotype	HP:0004332	Abnormality of lymphocytes	24	9.846524e-3	1.000000e+0	1.000000e+0	1.015587e+2	9.846524e-3	1	9.846524e-3	1.000000e+0	31	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	SLC29A3
Human Phenotype	HP:0002733	Abnormality of the lymph nodes	25	9.982206e-3	1.000000e+0	1.000000e+0	1.001783e+2	9.982206e-3	1	9.982206e-3	1.000000e+0	24	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	SLC29A3
Human Phenotype	HP:0000830	Anterior hypopituitarism	26	1.037809e-2	1.000000e+0	1.000000e+0	9.635685e+1	1.037809e-2	1	1.037809e-2	1.000000e+0	15	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	SLC29A3
Human Phenotype	HP:0004370	Abnormality of temperature regulation	27	1.075062e-2	1.000000e+0	1.000000e+0	9.301791e+1	1.075062e-2	1	1.075062e-2	1.000000e+0	33	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	SLC29A3
Human Phenotype	HP:0000135	Hypogonadism	28	1.170178e-2	1.000000e+0	1.000000e+0	8.545711e+1	1.170178e-2	1	1.170178e-2	1.000000e+0	21	1.017327e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	SLC29A3
Human Phenotype	HP:0003117	Abnormality of circulating hormone level	29	1.372152e-2	1.000000e+0	1.000000e+0	7.287820e+1	1.372152e-2	1	1.372152e-2	1.000000e+0	32	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	SLC29A3
Human Phenotype	HP:0000520	Proptosis	30	1.504190e-2	1.000000e+0	1.000000e+0	6.648097e+1	1.504190e-2	1	1.504190e-2	1.000000e+0	28	1.215761e-2	1.000000e+0	1.000000e+0	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	SLC29A3
Human Phenotype	HP:0011747	Abnormality of the anterior pituitary	31	1.529497e-2	1.000000e+0	1.000000e+0	6.538096e+1	1.529497e-2	1	1.529497e-2	1.000000e+0	19	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	SLC29A3
Human Phenotype	HP:0012503	Abnormality of the pituitary gland	32	1.556386e-2	1.000000e+0	1.000000e+0	6.425139e+1	1.556386e-2	1	1.556386e-2	1.000000e+0	21	1.017327e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	SLC29A3
Human Phenotype	HP:0009811	Abnormality of the elbow	33	1.589756e-2	1.000000e+0	1.000000e+0	6.290275e+1	1.589756e-2	1	1.589756e-2	1.000000e+0	30	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	SLC29A3
Human Phenotype	HP:0000819	Diabetes mellitus	34	1.619858e-2	1.000000e+0	1.000000e+0	6.173382e+1	1.619858e-2	1	1.619858e-2	1.000000e+0	43	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	SLC29A3
Human Phenotype	HP:0001744	Splenomegaly	35	1.639119e-2	1.000000e+0	1.000000e+0	6.100840e+1	1.639119e-2	1	1.639119e-2	1.000000e+0	47	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	SLC29A3
Human Phenotype	HP:0012385	Camptodactyly	36	1.801728e-2	1.000000e+0	1.000000e+0	5.550228e+1	1.801728e-2	1	1.801728e-2	1.000000e+0	35	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	SLC29A3
Human Phenotype	HP:0001903	Anemia	37	1.958596e-2	1.000000e+0	1.000000e+0	5.105699e+1	1.958596e-2	1	1.958596e-2	1.000000e+0	50	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	SLC29A3
Human Phenotype	HP:0100360	Contractures of the joints of the upper limbs	38	1.983296e-2	1.000000e+0	1.000000e+0	5.042111e+1	1.983296e-2	1	1.983296e-2	1.000000e+0	36	1.656012e-2	1.000000e+0	1.000000e+0	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	SLC29A3
Human Phenotype	HP:0000864	Abnormality of the hypothalamus-pituitary axis	39	1.993448e-2	1.000000e+0	1.000000e+0	5.016434e+1	1.993448e-2	1	1.993448e-2	1.000000e+0	33	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	SLC29A3
Human Phenotype	HP:0001631	Defect in the atrial septum	40	2.042369e-2	1.000000e+0	1.000000e+0	4.896274e+1	2.042369e-2	1	2.042369e-2	1.000000e+0	38	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	SLC29A3
Human Phenotype	HP:0005120	Abnormality of cardiac atrium	41	2.064140e-2	1.000000e+0	1.000000e+0	4.844632e+1	2.064140e-2	1	2.064140e-2	1.000000e+0	40	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	SLC29A3
Human Phenotype	HP:0001629	Ventricular septal defect	42	2.091358e-2	1.000000e+0	1.000000e+0	4.781582e+1	2.091358e-2	1	2.091358e-2	1.000000e+0	37	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	SLC29A3
Human Phenotype	HP:0001376	Limitation of joint mobility	43	2.093039e-2	1.000000e+0	1.000000e+0	4.777743e+1	2.093039e-2	1	2.093039e-2	1.000000e+0	46	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	SLC29A3
Human Phenotype	HP:0000080	Abnormality of genital physiology	44	2.101258e-2	1.000000e+0	1.000000e+0	4.759055e+1	2.101258e-2	1	2.101258e-2	1.000000e+0	41	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	SLC29A3
Human Phenotype	HP:0010438	Abnormality of the ventricular septum	45	2.136910e-2	1.000000e+0	1.000000e+0	4.679655e+1	2.136910e-2	1	2.136910e-2	1.000000e+0	38	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	SLC29A3
Human Phenotype	HP:0003121	Limb joint contracture	46	2.160499e-2	1.000000e+0	1.000000e+0	4.628560e+1	2.160499e-2	1	2.160499e-2	1.000000e+0	42	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	SLC29A3
Human Phenotype	HP:0002240	Hepatomegaly	47	2.226096e-2	1.000000e+0	1.000000e+0	4.492169e+1	2.226096e-2	1	2.226096e-2	1.000000e+0	53	3.200056e-2	1.000000e+0	1.000000e+0	3.099828e+1	3.225985e-2	1	291	5.000000e-1	3.436426e-3	unnamed	SLC29A3
Human Phenotype	HP:0008373	Puberty and gonadal disorders	48	2.230960e-2	1.000000e+0	1.000000e+0	4.482376e+1	2.230960e-2	1	2.230960e-2	1.000000e+0	44	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	SLC29A3
Human Phenotype	HP:0001877	Abnormality of erythrocytes	49	2.240890e-2	1.000000e+0	1.000000e+0	4.462513e+1	2.240890e-2	1	2.240890e-2	1.000000e+0	52	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	SLC29A3
Human Phenotype	HP:0001743	Abnormality of the spleen	50	2.315867e-2	1.000000e+0	1.000000e+0	4.318037e+1	2.315867e-2	1	2.315867e-2	1.000000e+0	51	3.003624e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	273	5.000000e-1	3.663004e-3	unnamed	SLC29A3
Human Phenotype	HP:0011014	Abnormal glucose homeostasis	51	2.584232e-2	1.000000e+0	1.000000e+0	3.869621e+1	2.584232e-2	1	2.584232e-2	1.000000e+0	54	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	SLC29A3
Human Phenotype	HP:0003271	Visceromegaly	52	2.717827e-2	1.000000e+0	1.000000e+0	3.679410e+1	2.717827e-2	1	2.717827e-2	1.000000e+0	61	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	SLC29A3
Human Phenotype	HP:0001713	Abnormality of cardiac ventricle	53	2.770630e-2	1.000000e+0	1.000000e+0	3.609287e+1	2.770630e-2	1	2.770630e-2	1.000000e+0	45	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	SLC29A3
Human Phenotype	HP:0001881	Abnormality of leukocytes	54	2.780174e-2	1.000000e+0	1.000000e+0	3.596897e+1	2.780174e-2	1	2.780174e-2	1.000000e+0	58	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	SLC29A3
Human Phenotype	HP:0011013	Abnormality of carbohydrate metabolism/homeostasis	55	2.907742e-2	1.000000e+0	1.000000e+0	3.439095e+1	2.907742e-2	1	2.907742e-2	1.000000e+0	60	3.799030e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	346	5.000000e-1	2.890173e-3	unnamed	SLC29A3
Human Phenotype	HP:0100763	Abnormality of the lymphatic system	56	2.916890e-2	1.000000e+0	1.000000e+0	3.428309e+1	2.916890e-2	1	2.916890e-2	1.000000e+0	59	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	SLC29A3
Human Phenotype	HP:0001671	Abnormality of the cardiac septa	57	3.031987e-2	1.000000e+0	1.000000e+0	3.298167e+1	3.031987e-2	1	3.031987e-2	1.000000e+0	48	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC29A3
Human Phenotype	HP:0003812	Phenotypic variability	58	3.032972e-2	1.000000e+0	1.000000e+0	3.297096e+1	3.032972e-2	1	3.032972e-2	1.000000e+0	54	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	SLC29A3
Human Phenotype	HP:0009810	Abnormality of the joints of the upper limbs	59	3.078029e-2	1.000000e+0	1.000000e+0	3.248832e+1	3.078029e-2	1	3.078029e-2	1.000000e+0	49	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	SLC29A3
Human Phenotype	HP:0001371	Flexion contracture	60	3.355127e-2	1.000000e+0	1.000000e+0	2.980513e+1	3.355127e-2	1	3.355127e-2	1.000000e+0	56	3.276392e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	298	5.000000e-1	3.355705e-3	unnamed	SLC29A3
Human Phenotype	HP:0001324	Muscle weakness	61	3.916358e-2	1.000000e+0	1.000000e+0	2.553393e+1	3.916358e-2	1	3.916358e-2	1.000000e+0	64	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	SLC29A3
Human Phenotype	HP:0001780	Abnormality of toe	62	4.021217e-2	1.000000e+0	1.000000e+0	2.486809e+1	4.021217e-2	1	4.021217e-2	1.000000e+0	57	3.309098e-2	1.000000e+0	1.000000e+0	2.996844e+1	3.336844e-2	1	301	5.000000e-1	3.322259e-3	unnamed	SLC29A3
Human Phenotype	HP:0010978	Abnormality of immune system physiology	63	4.120940e-2	1.000000e+0	1.000000e+0	2.426631e+1	4.120940e-2	1	4.120940e-2	1.000000e+0	68	5.336878e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	488	5.000000e-1	2.049180e-3	unnamed	SLC29A3
Human Phenotype	HP:0001392	Abnormality of the liver	64	4.545608e-2	1.000000e+0	1.000000e+0	2.199926e+1	4.545608e-2	1	4.545608e-2	1.000000e+0	71	6.154861e-2	1.000000e+0	1.000000e+0	1.599379e+1	6.252425e-2	1	564	5.000000e-1	1.773050e-3	unnamed	SLC29A3
Human Phenotype	HP:0100886	Abnormality of globe location	65	4.758118e-2	1.000000e+0	1.000000e+0	2.101671e+1	4.758118e-2	1	4.758118e-2	1.000000e+0	61	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	SLC29A3
Human Phenotype	HP:0000407	Sensorineural hearing impairment	66	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	65	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	SLC29A3
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	67	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	66	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	SLC29A3
Human Phenotype	HP:0000359	Abnormality of the inner ear	68	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	67	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	SLC29A3
Human Phenotype	HP:0000315	Abnormality of the orbital region	69	5.483513e-2	1.000000e+0	1.000000e+0	1.823648e+1	5.483513e-2	1	5.483513e-2	1.000000e+0	63	4.612818e-2	1.000000e+0	1.000000e+0	2.142637e+1	4.667147e-2	1	421	5.000000e-1	2.375297e-3	unnamed	SLC29A3
Human Phenotype	HP:0000818	Abnormality of the endocrine system	70	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	74	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	SLC29A3
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	71	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	87	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	SLC29A3
Human Phenotype	HP:0011729	Abnormality of joint mobility	72	6.014038e-2	1.000000e+0	1.000000e+0	1.662776e+1	6.014038e-2	1	6.014038e-2	1.000000e+0	69	5.670958e-2	1.000000e+0	1.000000e+0	1.738054e+1	5.753561e-2	1	519	5.000000e-1	1.926782e-3	unnamed	SLC29A3
Human Phenotype	HP:0004322	Short stature	73	6.307451e-2	1.000000e+0	1.000000e+0	1.585427e+1	6.307451e-2	1	6.307451e-2	1.000000e+0	73	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	SLC29A3
Human Phenotype	HP:0011805	Abnormality of muscle morphology	74	6.379056e-2	1.000000e+0	1.000000e+0	1.567630e+1	6.379056e-2	1	6.379056e-2	1.000000e+0	77	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	SLC29A3
Human Phenotype	HP:0011297	Abnormality of the digits	75	6.708382e-2	1.000000e+0	1.000000e+0	1.490672e+1	6.708382e-2	1	6.708382e-2	1.000000e+0	70	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	SLC29A3
Human Phenotype	HP:0000002	Abnormality of body height	76	6.858327e-2	1.000000e+0	1.000000e+0	1.458081e+1	6.858327e-2	1	6.858327e-2	1.000000e+0	75	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	SLC29A3
Human Phenotype	HP:0003549	Abnormality of connective tissue	77	6.968666e-2	1.000000e+0	1.000000e+0	1.434995e+1	6.968666e-2	1	6.968666e-2	1.000000e+0	76	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	SLC29A3
Human Phenotype	HP:0001760	Abnormality of the foot	78	7.004590e-2	1.000000e+0	1.000000e+0	1.427635e+1	7.004590e-2	1	7.004590e-2	1.000000e+0	72	6.176339e-2	1.000000e+0	1.000000e+0	1.593728e+1	6.274597e-2	1	566	5.000000e-1	1.766784e-3	unnamed	SLC29A3
Human Phenotype	HP:0002715	Abnormality of the immune system	79	7.036261e-2	1.000000e+0	1.000000e+0	1.421209e+1	7.036261e-2	1	7.036261e-2	1.000000e+0	89	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	SLC29A3
Human Phenotype	HP:0002564	Malformation of the heart and great vessels	80	7.308175e-2	1.000000e+0	1.000000e+0	1.368331e+1	7.308175e-2	1	7.308175e-2	1.000000e+0	79	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	SLC29A3
Human Phenotype	HP:0002817	Abnormality of the upper limb	81	7.338847e-2	1.000000e+0	1.000000e+0	1.362612e+1	7.338847e-2	1	7.338847e-2	1.000000e+0	77	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	SLC29A3
Human Phenotype	HP:0000365	Hearing impairment	82	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	82	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	SLC29A3
Human Phenotype	HP:0001627	Abnormality of the heart	83	7.369587e-2	1.000000e+0	1.000000e+0	1.356928e+1	7.369587e-2	1	7.369587e-2	1.000000e+0	80	7.129618e-2	1.000000e+0	1.000000e+0	1.377176e+1	7.261238e-2	1	655	5.000000e-1	1.526718e-3	unnamed	SLC29A3
Human Phenotype	HP:0000364	Hearing abnormality	84	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	83	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	SLC29A3
Human Phenotype	HP:0001367	Abnormal joint morphology	85	7.644753e-2	1.000000e+0	1.000000e+0	1.308087e+1	7.644753e-2	1	7.644753e-2	1.000000e+0	86	7.545814e-2	1.000000e+0	1.000000e+0	1.299784e+1	7.693587e-2	1	694	5.000000e-1	1.440922e-3	unnamed	SLC29A3
Human Phenotype	HP:0001510	Growth delay	86	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	88	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	SLC29A3
Human Phenotype	HP:0000078	Abnormality of the genital system	87	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	85	7.513832e-2	1.000000e+0	1.000000e+0	1.305427e+1	7.660329e-2	1	691	5.000000e-1	1.447178e-3	unnamed	SLC29A3
Human Phenotype	HP:0000284	Abnormality of the ocular region	88	8.041999e-2	1.000000e+0	1.000000e+0	1.243472e+1	8.041999e-2	1	8.041999e-2	1.000000e+0	81	7.204389e-2	1.000000e+0	1.000000e+0	1.362613e+1	7.338839e-2	1	662	5.000000e-1	1.510574e-3	unnamed	SLC29A3
Human Phenotype	HP:0002814	Abnormality of the lower limb	89	8.121304e-2	1.000000e+0	1.000000e+0	1.231329e+1	8.121304e-2	1	8.121304e-2	1.000000e+0	83	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	SLC29A3
Human Phenotype	HP:0000004	Onset and clinical course	90	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	92	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	SLC29A3
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	91	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	94	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	SLC29A3
Human Phenotype	HP:0011804	Abnormality of muscle physiology	92	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	93	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	SLC29A3
Human Phenotype	HP:0000951	Abnormality of the skin	93	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	96	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	SLC29A3
Human Phenotype	HP:0002813	Abnormality of limb bone morphology	94	1.016983e-1	1.000000e+0	1.000000e+0	9.833005e+0	1.016983e-1	1	1.016983e-1	1.000000e+0	90	9.665462e-2	1.000000e+0	1.000000e+0	1.009004e+1	9.910759e-2	1	894	5.000000e-1	1.118568e-3	unnamed	SLC29A3
Human Phenotype	HP:0011844	Abnormal appendicular skeleton morphology	95	1.019563e-1	1.000000e+0	1.000000e+0	9.808128e+0	1.019563e-1	1	1.019563e-1	1.000000e+0	91	9.728672e-2	1.000000e+0	1.000000e+0	1.002278e+1	9.977274e-2	1	900	5.000000e-1	1.111111e-3	unnamed	SLC29A3
Human Phenotype	HP:0000598	Abnormality of the ear	96	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	95	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	SLC29A3
Human Phenotype	HP:0012373	Abnormal eye physiology	97	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	98	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	SLC29A3
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	98	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	97	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	SLC29A3
Human Phenotype	HP:0012374	Abnormality of the globe	99	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	99	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	SLC29A3
Human Phenotype	HP:0012372	Abnormal eye morphology	100	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	101	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	SLC29A3
Human Phenotype	HP:0001507	Growth abnormality	101	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	100	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	SLC29A3
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	102	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	102	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	SLC29A3
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	103	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	107	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	SLC29A3
Human Phenotype	HP:0003011	Abnormality of the musculature	104	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	103	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	SLC29A3
Human Phenotype	HP:0001438	Abnormality of the abdomen	105	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	105	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	SLC29A3
Human Phenotype	HP:0001574	Abnormality of the integument	106	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	104	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	SLC29A3
Human Phenotype	HP:0000271	Abnormality of the face	107	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	106	1.358386e-1	1.000000e+0	1.000000e+0	7.102756e+0	1.407904e-1	1	1270	5.000000e-1	7.874016e-4	unnamed	SLC29A3
Human Phenotype	HP:0000007	Autosomal recessive inheritance	108	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	113	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	SLC29A3
Human Phenotype	HP:0000478	Abnormality of the eye	109	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	108	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	SLC29A3
Human Phenotype	HP:0000234	Abnormality of the head	110	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	110	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	SLC29A3
Human Phenotype	HP:0000152	Abnormality of head and neck	111	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	111	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	SLC29A3
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	112	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	109	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	SLC29A3
Human Phenotype	HP:0000924	Abnormality of the skeletal system	113	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	112	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	SLC29A3
Human Phenotype	HP:0000005	Mode of inheritance	114	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	114	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	SLC29A3
Human Phenotype	HP:0000118	Phenotypic abnormality	115	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	115	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	SLC29A3
Human Phenotype	HP:0000001	All	116	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	116	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	SLC29A3
Disease Ontology	DOID:9744	diabetes mellitus type 1	1	1.056421e-3	1.000000e+0	1.000000e+0	9.465921e+2	1.056421e-3	1	1.056421e-3	1.000000e+0	2	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	SLC29A3
Disease Ontology	DOID:420	hypertrichosis	2	1.564269e-3	1.000000e+0	1.000000e+0	6.392764e+2	1.564269e-3	1	1.564269e-3	1.000000e+0	1	3.325574e-4	7.432658e-1	7.432658e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	SLC29A3
Disease Ontology	DOID:3405	histiocytosis	3	3.981488e-3	1.000000e+0	1.000000e+0	2.511624e+2	3.981488e-3	1	3.981488e-3	1.000000e+0	3	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	SLC29A3
Disease Ontology	DOID:421	hair disease	4	8.104961e-3	1.000000e+0	1.000000e+0	1.233812e+2	8.104961e-3	1	8.104961e-3	1.000000e+0	4	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	SLC29A3
Disease Ontology	DOID:0060005	autoimmune disease of endocrine system	5	9.664126e-3	1.000000e+0	1.000000e+0	1.034755e+2	9.664126e-3	1	9.664126e-3	1.000000e+0	5	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	SLC29A3
Disease Ontology	DOID:16	integumentary system disease	6	5.565040e-2	1.000000e+0	1.000000e+0	1.796932e+1	5.565040e-2	1	5.565040e-2	1.000000e+0	6	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	SLC29A3
Disease Ontology	DOID:417	autoimmune disease	7	7.426329e-2	1.000000e+0	1.000000e+0	1.346560e+1	7.426329e-2	1	7.426329e-2	1.000000e+0	7	8.820552e-2	1.000000e+0	1.000000e+0	1.108170e+1	9.023890e-2	1	814	5.000000e-1	1.228501e-3	unnamed	SLC29A3
Disease Ontology	DOID:9351	diabetes mellitus	8	9.310870e-2	1.000000e+0	1.000000e+0	1.074013e+1	9.310870e-2	1	9.310870e-2	1.000000e+0	8	9.465152e-2	1.000000e+0	1.000000e+0	1.030914e+1	9.700127e-2	1	875	5.000000e-1	1.142857e-3	unnamed	SLC29A3
Disease Ontology	DOID:1428	endocrine pancreas disease	9	9.553022e-2	1.000000e+0	1.000000e+0	1.046789e+1	9.553022e-2	1	9.553022e-2	1.000000e+0	9	9.654925e-2	1.000000e+0	1.000000e+0	1.010134e+1	9.899673e-2	1	893	5.000000e-1	1.119821e-3	unnamed	SLC29A3
Disease Ontology	DOID:4194	glucose metabolism disease	10	9.709597e-2	1.000000e+0	1.000000e+0	1.029909e+1	9.709597e-2	1	9.709597e-2	1.000000e+0	10	9.844499e-2	1.000000e+0	1.000000e+0	9.901756e+0	1.009922e-1	1	911	5.000000e-1	1.097695e-3	unnamed	SLC29A3
Disease Ontology	DOID:26	pancreas disease	11	9.807021e-2	1.000000e+0	1.000000e+0	1.019678e+1	9.807021e-2	1	9.807021e-2	1.000000e+0	11	1.001284e-1	1.000000e+0	1.000000e+0	9.730852e+0	1.027659e-1	1	927	5.000000e-1	1.078749e-3	unnamed	SLC29A3
Disease Ontology	DOID:0050013	carbohydrate metabolism disease	12	1.011074e-1	1.000000e+0	1.000000e+0	9.890476e+0	1.011074e-1	1	1.011074e-1	1.000000e+0	12	1.026506e-1	1.000000e+0	1.000000e+0	9.485279e+0	1.054265e-1	1	951	5.000000e-1	1.051525e-3	unnamed	SLC29A3
Disease Ontology	DOID:75	lymphatic system disease	13	1.035697e-1	1.000000e+0	1.000000e+0	9.655335e+0	1.035697e-1	1	1.035697e-1	1.000000e+0	13	1.052741e-1	1.000000e+0	1.000000e+0	9.242316e+0	1.081980e-1	1	976	5.000000e-1	1.024590e-3	unnamed	SLC29A3
Disease Ontology	DOID:28	endocrine system disease	14	1.359578e-1	1.000000e+0	1.000000e+0	7.355222e+0	1.359578e-1	1	1.359578e-1	1.000000e+0	14	1.392361e-1	1.000000e+0	1.000000e+0	6.922870e+0	1.444488e-1	1	1303	5.000000e-1	7.674597e-4	unnamed	SLC29A3
Disease Ontology	DOID:0014667	disease of metabolism	15	1.387898e-1	1.000000e+0	1.000000e+0	7.205143e+0	1.387898e-1	1	1.387898e-1	1.000000e+0	15	1.487750e-1	1.000000e+0	1.000000e+0	6.461676e+0	1.547586e-1	1	1396	5.000000e-1	7.163324e-4	unnamed	SLC29A3
Disease Ontology	DOID:77	gastrointestinal system disease	16	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	16	1.749595e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	1654	5.000000e-1	6.045949e-4	unnamed	SLC29A3
Disease Ontology	DOID:225	syndrome	17	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	17	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	SLC29A3
Disease Ontology	DOID:1287	cardiovascular system disease	18	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	18	2.586189e-1	1.000000e+0	1.000000e+0	3.598125e+0	2.779225e-1	1	2507	5.000000e-1	3.988831e-4	unnamed	SLC29A3
Disease Ontology	DOID:2985	chronic rejection of renal transplant	19	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	19	2.866046e-1	1.000000e+0	1.000000e+0	3.218159e+0	3.107367e-1	1	2803	5.000000e-1	3.567606e-4	unnamed	SLC29A3
Disease Ontology	DOID:2108	transplant-related disease	20	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	20	2.866982e-1	1.000000e+0	1.000000e+0	3.217011e+0	3.108475e-1	1	2804	5.000000e-1	3.566334e-4	unnamed	SLC29A3
Disease Ontology	DOID:557	kidney disease	21	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	21	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	SLC29A3
Disease Ontology	DOID:18	urinary system disease	22	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	22	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	SLC29A3
Disease Ontology	DOID:2914	immune system disease	23	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	23	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	SLC29A3
Disease Ontology	DOID:162	cancer	24	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	24	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	SLC29A3
Disease Ontology	DOID:7	disease of anatomical entity	25	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	25	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	SLC29A3
Disease Ontology	DOID:4	disease	26	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	26	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	SLC29A3
MSigDB Pathway	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	Genes involved in Transport of vitamins, nucleosides, and related molecules	1	2.788727e-3	1.000000e+0	1.000000e+0	3.585866e+2	2.788727e-3	1	2.788727e-3	1.000000e+0	1	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	SLC29A3
MSigDB Pathway	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	Genes involved in SLC-mediated transmembrane transport	2	2.225408e-2	1.000000e+0	1.000000e+0	4.493558e+1	2.225408e-2	1	2.225408e-2	1.000000e+0	2	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	SLC29A3
MSigDB Pathway	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	Genes involved in Transmembrane transport of small molecules	3	3.726554e-2	1.000000e+0	1.000000e+0	2.683444e+1	3.726554e-2	1	3.726554e-2	1.000000e+0	3	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	SLC29A3
MSigDB Perturbation	SAFFORD_T_LYMPHOCYTE_ANERGY	Genes up-regulated in anergic mouse T helper cells (A.E7), versus non-anergic stimulated controls	1	1.017176e-2	1.000000e+0	1.000000e+0	9.831139e+1	1.017176e-2	1	1.017176e-2	1.000000e+0	3	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	SLC29A3
MSigDB Perturbation	BHAT_ESR1_TARGETS_VIA_AKT1_DN	Genes bound by ESR1 [GeneID=2099] and down-regulated by estradiol [PubChemID=5757] in MCF-7 cells (breast cancer) expressing constitutevly active form of AKT1 [GeneID=207].	2	1.277487e-2	1.000000e+0	1.000000e+0	7.827867e+1	1.277487e-2	1	1.277487e-2	1.000000e+0	1	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	SLC29A3
MSigDB Perturbation	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	Genes bound by ESR1 [GeneID=2099] and down-regulated by estradiol [PubChemID=5757] in MCF-7 cells (breast cancer).	3	1.615768e-2	1.000000e+0	1.000000e+0	6.189007e+1	1.615768e-2	1	1.615768e-2	1.000000e+0	2	9.290700e-3	1.000000e+0	1.000000e+0	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	SLC29A3
MSigDB Perturbation	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	Genes up-regulated in acute myeloid leukemia (AML) with respect to cellular localization of NPM1 [GeneID=4869]: cytoplasmic vs. nucleolar.	4	1.753124e-2	1.000000e+0	1.000000e+0	5.704102e+1	1.753124e-2	1	1.753124e-2	1.000000e+0	4	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	SLC29A3
MSigDB Perturbation	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	Genes whose expression in optimally debulked ovarian tumors is associated with survival prognosis.	5	2.457305e-2	1.000000e+0	1.000000e+0	4.069499e+1	2.457305e-2	1	2.457305e-2	1.000000e+0	7	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC29A3
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	Genes down-regulated in macrophages by P.gingivalis FimA pathogen.	6	2.966377e-2	1.000000e+0	1.000000e+0	3.371116e+1	2.966377e-2	1	2.966377e-2	1.000000e+0	8	2.796063e-2	1.000000e+0	1.000000e+0	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	SLC29A3
MSigDB Perturbation	DOANE_RESPONSE_TO_ANDROGEN_DN	Genes down-regulated in MDA-MB-453 cells (class A ER(-) [GeneID=2099] breast cancer) after exposure to the androgen R1881 [PubChem=13766].	7	2.973318e-2	1.000000e+0	1.000000e+0	3.363246e+1	2.973318e-2	1	2.973318e-2	1.000000e+0	6	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	SLC29A3
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	Genes down-regulated in macrophage by live P.gingivalis.	8	3.254483e-2	1.000000e+0	1.000000e+0	3.072684e+1	3.254483e-2	1	3.254483e-2	1.000000e+0	10	3.853390e-2	1.000000e+0	1.000000e+0	2.569943e+1	3.891137e-2	1	351	5.000000e-1	2.849003e-3	unnamed	SLC29A3
MSigDB Perturbation	VERHAAK_GLIOBLASTOMA_CLASSICAL	Genes correlated with classical type of glioblastoma multiforme tumors.	9	3.391831e-2	1.000000e+0	1.000000e+0	2.948260e+1	3.391831e-2	1	3.391831e-2	1.000000e+0	5	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	SLC29A3
MSigDB Perturbation	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	Genes up-regulated in peripheral blood monocytes by CSF2RB (GM-CSF) and IL4 [GeneID=1437;3565].	10	3.900660e-2	1.000000e+0	1.000000e+0	2.563668e+1	3.900660e-2	1	3.900660e-2	1.000000e+0	9	3.614091e-2	1.000000e+0	1.000000e+0	2.741793e+1	3.647248e-2	1	329	5.000000e-1	3.039514e-3	unnamed	SLC29A3
MSigDB Perturbation	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	Genes up-regulated in peripheral blood mononucleocytes by HGF [GeneID=3082] compared to those regulated by CSF2RB (GM-CSF) and IL4 [GeneID=1437;3565].	11	4.168157e-2	1.000000e+0	1.000000e+0	2.399142e+1	4.168157e-2	1	4.168157e-2	1.000000e+0	11	4.374465e-2	1.000000e+0	1.000000e+0	2.260777e+1	4.423258e-2	1	399	5.000000e-1	2.506266e-3	unnamed	SLC29A3
MSigDB Perturbation	RUTELLA_RESPONSE_TO_HGF_UP	Genes up-regulated in peripheral blood monocytes by HGF [GeneID=3082].	12	4.404194e-2	1.000000e+0	1.000000e+0	2.270563e+1	4.404194e-2	1	4.404194e-2	1.000000e+0	12	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	SLC29A3
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	Genes up-regulated in liver tumor compared to the normal adjacent tissue.	13	6.025185e-2	1.000000e+0	1.000000e+0	1.659700e+1	6.025185e-2	1	6.025185e-2	1.000000e+0	13	9.169554e-2	1.000000e+0	1.000000e+0	1.064994e+1	9.389723e-2	1	847	5.000000e-1	1.180638e-3	unnamed	SLC29A3
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_UP	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	14	7.903216e-2	1.000000e+0	1.000000e+0	1.265308e+1	7.903216e-2	1	7.903216e-2	1.000000e+0	14	1.017052e-1	1.000000e+0	1.000000e+0	9.575902e+0	1.044288e-1	1	942	5.000000e-1	1.061571e-3	unnamed	SLC29A3
MSigDB Perturbation	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY	Genes transiently induced only by the first pulse of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	15	1.656740e-1	1.000000e+0	1.000000e+0	6.035952e+0	1.656740e-1	1	1.656740e-1	1.000000e+0	15	1.708257e-1	1.000000e+0	1.000000e+0	5.592374e+0	1.788149e-1	1	1613	5.000000e-1	6.199628e-4	unnamed	SLC29A3
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	16	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	16	2.003385e-1	1.000000e+0	1.000000e+0	4.727725e+0	2.115182e-1	1	1908	5.000000e-1	5.241090e-4	unnamed	SLC29A3
MSigDB Predicted Promoter Motifs	V$PITX2_Q2	Motif WNTAATCCCAR matches PITX2: paired-like homeodomain transcription factor 2	1	4.279605e-2	1.000000e+0	1.000000e+0	2.336664e+1	4.279605e-2	1	4.279605e-2	1.000000e+0	1	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	SLC29A3
MSigDB Predicted Promoter Motifs	TATAAA_V$TATA_01	Motif TATAAA matches TAF&lt;br&gt; TATA	2	1.585244e-1	1.000000e+0	1.000000e+0	6.308178e+0	1.585244e-1	1	1.585244e-1	1.000000e+0	2	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	SLC29A3
InterPro	IPR002259	Equilibrative nucleoside transporter	1	3.085876e-4	1.000000e+0	1.000000e+0	3.240570e+3	3.085876e-4	1	3.085876e-4	1.000000e+0	1	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	SLC29A3
TreeFam	TF313950	SLC29A1, SLC29A2, SLC29A3, SLC29A4	1	3.085876e-4	1.000000e+0	1.000000e+0	3.240570e+3	3.085876e-4	1	3.085876e-4	1.000000e+0	1	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	SLC29A3
HGNC Gene Families	SLC	SLC	1	3.126915e-2	1.000000e+0	1.000000e+0	3.198041e+1	3.126915e-2	1	3.126915e-2	1.000000e+0	1	4.070677e-2	1.000000e+0	1.000000e+0	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	SLC29A3
Ensembl Genes	2403	C10orf105	1	1.580517e-4	1.000000e+0	1.000000e+0	6.327045e+3	1.580517e-4	1	1.580517e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	C10orf105
Ensembl Genes	2402	SLC29A3	2	1.765782e-4	1.000000e+0	1.000000e+0	5.663212e+3	1.765782e-4	1	1.765782e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC29A3
MSigDB Oncogenic Signatures	DCA_UP.V1_DN	Genes down-regulated in A549 lung carcinoma and M059K glioblastoma cells treated with dichloroacetate [PubChem=6597].	1	1.624262e-2	1.000000e+0	1.000000e+0	6.156641e+1	1.624262e-2	1	1.624262e-2	1.000000e+0	2	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	SLC29A3
MSigDB Oncogenic Signatures	ATF2_S_UP.V1_DN	Genes down-regulated in myometrial cells over-expressing a shortened splice form of ATF2 [Gene ID=1386] gene.	2	2.304423e-2	1.000000e+0	1.000000e+0	4.339481e+1	2.304423e-2	1	2.304423e-2	1.000000e+0	1	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	SLC29A3
MSigDB Oncogenic Signatures	KRAS.600_UP.V1_DN	Genes down-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	3	2.550358e-2	1.000000e+0	1.000000e+0	3.921018e+1	2.550358e-2	1	2.550358e-2	1.000000e+0	3	3.069123e-2	1.000000e+0	1.000000e+0	3.233154e+1	3.092955e-2	1	279	5.000000e-1	3.584229e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_4H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 4 h versus those stimulated with CpG DNA (TLR9 agonist) at 4 h.	1	1.390761e-2	1.000000e+0	1.000000e+0	7.190309e+1	1.390761e-2	1	1.390761e-2	1.000000e+0	22	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_6H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 6 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 6 h.	2	1.411913e-2	1.000000e+0	1.000000e+0	7.082588e+1	1.411913e-2	1	1.411913e-2	1.000000e+0	12	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN	Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 7 days.	3	1.506684e-2	1.000000e+0	1.000000e+0	6.637091e+1	1.506684e-2	1	1.506684e-2	1.000000e+0	28	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Gardiquimod (TLR7 agonist) at 0.5 h versus those stimulated with Gardiquimod (TLR7 agonist) at 8 h.	4	1.520813e-2	1.000000e+0	1.000000e+0	6.575428e+1	1.520813e-2	1	1.520813e-2	1.000000e+0	26	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP	Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	5	1.526010e-2	1.000000e+0	1.000000e+0	6.553037e+1	1.526010e-2	1	1.526010e-2	1.000000e+0	3	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 4 h versus those stimulated with Gardiquimod (TLR7 agonist) at 4 h.	6	1.560752e-2	1.000000e+0	1.000000e+0	6.407168e+1	1.560752e-2	1	1.560752e-2	1.000000e+0	15	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 16 h.	7	1.625035e-2	1.000000e+0	1.000000e+0	6.153715e+1	1.625035e-2	1	1.625035e-2	1.000000e+0	18	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP	Genes up-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 16 h after LPS (TLR4 agonist) stimulation.	8	1.652253e-2	1.000000e+0	1.000000e+0	6.052343e+1	1.652253e-2	1	1.652253e-2	1.000000e+0	1	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN	Genes down-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.	9	1.662937e-2	1.000000e+0	1.000000e+0	6.013458e+1	1.662937e-2	1	1.662937e-2	1.000000e+0	28	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_12H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with CpG DNA (TLR9 agonist) at 12 h.	10	1.704319e-2	1.000000e+0	1.000000e+0	5.867445e+1	1.704319e-2	1	1.704319e-2	1.000000e+0	22	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN	Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.	11	1.764296e-2	1.000000e+0	1.000000e+0	5.667984e+1	1.764296e-2	1	1.764296e-2	1.000000e+0	22	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_BASOPHIL_UP	Genes up-regulated in comparison of mast cells versus basophils.	12	1.772587e-2	1.000000e+0	1.000000e+0	5.641471e+1	1.772587e-2	1	1.772587e-2	1.000000e+0	15	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP	Genes up-regulated in comparison of untreated macrophages at 4 h versus those treated with LPS (TLR4 agonist) at 4 h.	13	1.797928e-2	1.000000e+0	1.000000e+0	5.561958e+1	1.797928e-2	1	1.797928e-2	1.000000e+0	6	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h.	14	1.798644e-2	1.000000e+0	1.000000e+0	5.559743e+1	1.798644e-2	1	1.798644e-2	1.000000e+0	27	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells from mice challenged with LCMV versus those challenged with Listeria-gp61.	15	1.830342e-2	1.000000e+0	1.000000e+0	5.463460e+1	1.830342e-2	1	1.830342e-2	1.000000e+0	7	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN	Genes down-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.	16	1.888609e-2	1.000000e+0	1.000000e+0	5.294903e+1	1.888609e-2	1	1.888609e-2	1.000000e+0	22	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 16 h.	17	1.945462e-2	1.000000e+0	1.000000e+0	5.140168e+1	1.945462e-2	1	1.945462e-2	1.000000e+0	21	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_POLYIC_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus those stimulated at 24 h.	18	1.995300e-2	1.000000e+0	1.000000e+0	5.011778e+1	1.995300e-2	1	1.995300e-2	1.000000e+0	13	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE7852_TREG_VS_TCONV_THYMUS_DN	Genes down-regulated in comparison of thymus regulatory T cells versus thymus conventional T cells.	19	2.005091e-2	1.000000e+0	1.000000e+0	4.987304e+1	2.005091e-2	1	2.005091e-2	1.000000e+0	3	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP	Genes up-regulated in comparison of untreated wild type macrophages at 1 h versus those from IRAK4 [GeneID=51135] deficient mice treated with LPS (TLR4 agonist) at 1 h.	20	2.007240e-2	1.000000e+0	1.000000e+0	4.981964e+1	2.007240e-2	1	2.007240e-2	1.000000e+0	9	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_24H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 24 h versus those stimulated with poly(I:C) (TLR3 agonist) at 24 h.	21	2.021489e-2	1.000000e+0	1.000000e+0	4.946848e+1	2.021489e-2	1	2.021489e-2	1.000000e+0	18	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_12H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with poly(I:C) (TLR3 agonist) at 12 h.	22	2.035731e-2	1.000000e+0	1.000000e+0	4.912240e+1	2.035731e-2	1	2.035731e-2	1.000000e+0	15	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE14350_IL2RB_KO_VS_WT_TEFF_UP	Genes up-regulated in comparison of effector T cells from IL2RB [GeneID=3560] defficient mice versus effector T cells from wild type animals.	23	2.037135e-2	1.000000e+0	1.000000e+0	4.908854e+1	2.037135e-2	1	2.037135e-2	1.000000e+0	3	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	24	2.047346e-2	1.000000e+0	1.000000e+0	4.884371e+1	2.047346e-2	1	2.047346e-2	1.000000e+0	2	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP	Genes up-regulated in comparison of control macrophages versus macrophages treated with interferon alpha.	25	2.084610e-2	1.000000e+0	1.000000e+0	4.797060e+1	2.084610e-2	1	2.084610e-2	1.000000e+0	9	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE24142_DN2_VS_DN3_THYMOCYTE_DN	Genes down-regulated in comparison of DN2 thymocytes versus DN3 thymocytes.	26	2.140277e-2	1.000000e+0	1.000000e+0	4.672292e+1	2.140277e-2	1	2.140277e-2	1.000000e+0	18	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 8 h.	27	2.215767e-2	1.000000e+0	1.000000e+0	4.513109e+1	2.215767e-2	1	2.215767e-2	1.000000e+0	30	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN	Genes down-regulated in adult DN2 thymocytes versus adult DN3 thymocytes.	28	2.467156e-2	1.000000e+0	1.000000e+0	4.053249e+1	2.467156e-2	1	2.467156e-2	1.000000e+0	7	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP	Genes up-regulated in comparison of adult thymic progenitors versus adult DN2 thymocytes.	29	2.621064e-2	1.000000e+0	1.000000e+0	3.815245e+1	2.621064e-2	1	2.621064e-2	1.000000e+0	9	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	SLC29A3
MSigDB Immunologic Signatures	GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN	Genes down-regulated in comparison of Homeo Convert versus Homeo Foxp3- (see Table 1S in the paper for details).	30	2.631628e-2	1.000000e+0	1.000000e+0	3.799929e+1	2.631628e-2	1	2.631628e-2	1.000000e+0	13	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC29A3
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
